In a study by Madsen [20], administering GLP-1 and GLP-2 to SBS patients reduced stoma output, and losses of energy and minerals. The gene discussed is GCG; the disease is macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss.